Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “or Severe Renal Impairment”

72 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 72 results

Early research (Phase 1)Study completedNCT01875523
What this trial is testing

PK of Serelaxin in Severe Renal Impairment and ESRD

Who this might be right for
Renal Failure, ChronicEnd-Stage Renal Disease
Novartis Pharmaceuticals 36
Post-approval studies (Phase 4)Looking for participantsNCT06402851
What this trial is testing

Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE)

Who this might be right for
Atrium; FibrillationChronic Kidney Diseases
Hospital Sirio-Libanes 1,500
Large-scale testing (Phase 3)Study completedNCT01968044
What this trial is testing

A Phase IIIb Study to Evaluate the Safety and Efficacy of Gemigliptin in Type 2 Diabetes Mellitus Patients With Moderate or Severe Renal Impairment(GUARD Study)

Who this might be right for
Type 2 DM Patients With Moderate or Severe Renal Impairment
LG Life Sciences 132
Post-approval studies (Phase 4)Ended earlyNCT01104662
What this trial is testing

Study of Daptomycin Safety and Efficacy for Complicated Skin and Skin Structure Infections (cSSSI) and Bacteremia in Renal Impairment

Who this might be right for
Complicated Skin and Skin Structure InfectionsS. Aureus BacteremiaRenal Impairment
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 92
Early research (Phase 1)Study completedNCT00863161
What this trial is testing

Renal Impairment Study

Who this might be right for
RefluxRenal Excretion
AstraZeneca 23
Early research (Phase 1)Study completedNCT00442871
What this trial is testing

Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal Impairment

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 29
Early research (Phase 1)Active Not RecruitingNCT07168356
What this trial is testing

Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease

Who this might be right for
Hepatitis B
GlaxoSmithKline 32
Early research (Phase 1)WithdrawnNCT02325024
What this trial is testing

Evaluate the Pharmacokinetics Of Sativex® in Subjects With Severe Renal Impairment or End Stage Renal Disease, Compared to Matched Subjects With Normal Renal Function.

Who this might be right for
Renal InsufficiencyKidney Disease
GW Pharmaceuticals Ltd
Not applicableStudy completedNCT04841785
What this trial is testing

RECOVAC - Long Term Efficacy and Safety of COVID-19 (SARS-CoV-2) Vaccination in Kidney Disease Patients

Who this might be right for
Covid19SARS-CoV InfectionChronic Kidney Diseases
University Medical Center Groningen 4,868
Early research (Phase 1)Study completedNCT03443063
What this trial is testing

Study to Evaluate the Pharmacokinetics of Lemborexant (E2006) and Its Metabolites in Subjects With Normal Renal Function or With Severe Renal Impairment

Who this might be right for
Renal Impairment
Eisai Inc. 16
Early research (Phase 1)Study completedNCT03814005
What this trial is testing

Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicLeukemia, Myeloid, Acute+3 more
Takeda 17
Post-approval studies (Phase 4)UnknownNCT00837057
What this trial is testing

Early Continuous Renal Replacement Therapies (CRRT) in Patients With Severe Sepsis or Septic Shock With Acute Kidney Injury

Who this might be right for
Severe SepsisSeptic ShockAcute Kidney Injury
Asan Medical Center 60
Not applicableLooking for participantsNCT03836482
What this trial is testing

Feasibility of the SCD in Cardiorenal Syndrome Patients Awaiting LVAD

Who this might be right for
Acute on Chronic Systolic Congestive Heart FailureCardiorenal Syndrome
SeaStar Medical 20
Early research (Phase 1)Study completedNCT05704556
What this trial is testing

Evaluation of the Pharmacokinetics and Safety of VX-548 in Participants With Renal Impairment

Who this might be right for
Pain
Vertex Pharmaceuticals Incorporated 38
Not applicableStudy completedNCT05788211
What this trial is testing

REnal reCOVery After ECMO for Cardiogenic Shock (RECOVECMO)

Who this might be right for
Cardiogenic ShockRenal Replacement TherapyVenoarterial Extracorporeal Membrane Oxygenation
University Hospital, Bordeaux 93
Large-scale testing (Phase 3)Study completedNCT00765830
What this trial is testing

Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension)

Who this might be right for
Diabetes Mellitus, Type 2Renal Insufficiency
Novartis 349
Early research (Phase 1)Study completedNCT01393964
What this trial is testing

Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 35
Early research (Phase 1)Study completedNCT02275156
What this trial is testing

Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of Evolocumab

Who this might be right for
HyperlipidemiaMixed Dyslipidemia
Amgen 18
Not applicableStudy completedNCT04285983
What this trial is testing

Specified Drug-Use Survey of Trelagliptin Tablets "Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Severe Renal Impairment or End-stage Renal Disease"

Who this might be right for
Type 2 Diabetes Mellitus
Takeda 89
Early research (Phase 1)Study completedNCT01830816
What this trial is testing

Pharmacokinetics Study of Oral Ixazomib (MLN9708) in Relapsed/Refractory Multiple Myeloma and Advanced Solid Tumors Participants With Normal Renal Function or Severe Renal Impairment

Who this might be right for
Multiple MyelomaAdvanced Solid Tumors
Millennium Pharmaceuticals, Inc. 41
Next Page